Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 138

1.

A fixed-dose study of alprazolam 2 mg, alprazolam 6 mg, and placebo in panic disorder.

Lydiard RB, Lesser IM, Ballenger JC, Rubin RT, Laraia M, DuPont R.

J Clin Psychopharmacol. 1992 Apr;12(2):96-103.

PMID:
1573046
2.

Plasma alprazolam concentrations. Relation to efficacy and side effects in the treatment of panic disorder.

Greenblatt DJ, Harmatz JS, Shader RI.

Arch Gen Psychiatry. 1993 Sep;50(9):715-22.

PMID:
8357297
3.

A double-blind, placebo-controlled, multicenter study with alprazolam and extended-release alprazolam in the treatment of panic disorder.

Pecknold J, Luthe L, Munjack D, Alexander P.

J Clin Psychopharmacol. 1994 Oct;14(5):314-21.

PMID:
7806686
4.

A controlled study of alprazolam and propranolol in panic-disordered and agoraphobic outpatients.

Ravaris CL, Friedman MJ, Hauri PJ, McHugo GJ.

J Clin Psychopharmacol. 1991 Dec;11(6):344-50.

PMID:
1770152
5.

Maintenance drug therapy of panic disorder.

Curtis GC, Massana J, Udina C, Ayuso JL, Cassano GB, Perugi G.

J Psychiatr Res. 1993;27 Suppl 1:127-42.

7.

Response of panic disorder to fixed doses of alprazolam or imipramine.

Uhlenhuth EH, Matuzas W, Glass RM, Easton C.

J Affect Disord. 1989 Nov-Dec;17(3):261-70.

PMID:
2529295
8.

A double-blind study of the efficacy of venlafaxine extended-release, paroxetine, and placebo in the treatment of panic disorder.

Pollack MH, Lepola U, Koponen H, Simon NM, Worthington JJ, Emilien G, Tzanis E, Salinas E, Whitaker T, Gao B.

Depress Anxiety. 2007;24(1):1-14.

PMID:
16894619
9.

Maintenance drug treatment of panic disorder. I. Results of a prospective, placebo-controlled comparison of alprazolam and imipramine.

Schweizer E, Rickels K, Weiss S, Zavodnick S.

Arch Gen Psychiatry. 1993 Jan;50(1):51-60.

PMID:
8422222
10.

Behavioural aggression in panic disorder after 8 weeks' treatment with alprazolam.

Bond AJ, Curran HV, Bruce MS, O'Sullivan G, Shine P.

J Affect Disord. 1995 Dec 13;35(3):117-23.

PMID:
8749839
11.

Alprazolam premedication and 35% carbon dioxide vulnerability in panic patients.

Pols H, Verburg K, Hauzer R, Meijer J, Griez E.

Biol Psychiatry. 1996 Nov 1;40(9):913-7.

PMID:
8896779
12.

Discontinuation reactions to alprazolam in panic disorder.

Pecknold JC.

J Psychiatr Res. 1993;27 Suppl 1:155-70.

PMID:
8145176
13.

Do antidepressants selectively suppress spontaneous (unexpected) panic attacks? A replication.

Uhlenhuth EH, Matuzas W, Warner TD, Paine S, Lydiard RB, Pollack MH.

J Clin Psychopharmacol. 2000 Dec;20(6):622-7.

PMID:
11106133
14.

Alprazolam plasma concentrations and treatment response in panic disorder and agoraphobia.

Lesser IM, Lydiard RB, Antal E, Rubin RT, Ballenger JC, DuPont R.

Am J Psychiatry. 1992 Nov;149(11):1556-62.

PMID:
1415824
15.

The speed of onset of action of alprazolam-XR compared to alprazolam-CT in panic disorder.

Sheehan DV, Sheehan KH, Raj BA.

Psychopharmacol Bull. 2007;40(2):63-81.

PMID:
17514187
16.

The relationship of alprazolam dose to steady-state plasma concentrations.

Ciraulo DA, Antal EJ, Smith RB, Olson DR, Goldberg DA, Rand EH, Raskin RB, Phillips JP, Shader RI, Greenblatt DJ.

J Clin Psychopharmacol. 1990 Feb;10(1):27-32.

PMID:
2407754
17.

Three-year follow-up of patients with panic disorder after short-term treatment with alprazolam and imipramine.

Lepola UM, Rimón RH, Riekkinen PJ.

Int Clin Psychopharmacol. 1993 Summer;8(2):115-8.

PMID:
8345160
18.

Safety and side-effects of alprazolam. Controlled study in agoraphobia with panic disorder.

O'Sullivan GH, Noshirvani H, Başoğlu M, Marks IM, Swinson R, Kuch K, Kirby M.

Br J Psychiatry. 1994 Jul;165(1):79-86.

PMID:
7802851
19.

Diazepam versus alprazolam for the treatment of panic disorder.

Noyes R Jr, Burrows GD, Reich JH, Judd FK, Garvey MJ, Norman TR, Cook BL, Marriott P.

J Clin Psychiatry. 1996 Aug;57(8):349-55.

PMID:
8752017
20.

The relationship of alprazolam and clonazepam dose to steady-state concentration in plasma.

Labbate LA, Pollack MH, Otto MW, Tesar GM, Rosenbaum JF.

J Clin Psychopharmacol. 1994 Aug;14(4):274-6.

PMID:
7962684

Supplemental Content

Support Center